• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nasdaq threatens Cedara delisting

Article

Canadian software developer Cedara has been notified by Nasdaq that the company does not comply with basic criteria to maintain its listing on the Nasdaq Small Cap stock exchange. Stock price and stockholder equity have dropped below minimums, according

Canadian software developer Cedara has been notified by Nasdaq that the company does not comply with basic criteria to maintain its listing on the Nasdaq Small Cap stock exchange. Stock price and stockholder equity have dropped below minimums, according to the company. Cedara plans to request a hearing before a Nasdaq Listing Qualifications Panel to review the determination and to discuss potential actions to achieve compliance.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.